BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35961535)

  • 1. 5-Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional antimetabolite.
    Lee BWH; Sidhu AS; Francis IC; Coroneo MT
    Ocul Surf; 2022 Oct; 26():128-141. PubMed ID: 35961535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium.
    Prabhasawat P; Tesavibul N; Leelapatranura K; Phonjan T
    Ophthalmology; 2006 Jul; 113(7):1102-9. PubMed ID: 16730066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology.
    Kaufman SC; Jacobs DS; Lee WB; Deng SX; Rosenblatt MI; Shtein RM
    Ophthalmology; 2013 Jan; 120(1):201-8. PubMed ID: 23062647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjunctival autograft for pterygium.
    Clearfield E; Muthappan V; Wang X; Kuo IC
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011349. PubMed ID: 26867004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pterygium treatment using 5-FU as adjuvant treatment compared to conjunctiva autograft.
    Bekibele CO; Baiyeroju AM; Olusanya BA; Ashaye AO; Oluleye TS
    Eye (Lond); 2008 Jan; 22(1):31-4. PubMed ID: 16778821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-fluorouracil vs. beta-irradiation in the prevention of pterygium recurrence.
    Bekibele CO; Baiyeroju AM; Ajayi BG
    Int J Clin Pract; 2004 Oct; 58(10):920-3. PubMed ID: 15587769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular surface changes in recurrent pterygium cases post-operatively treated with 5-fluorouracil subconjunctival injections.
    García Tirado A; Boto de Los Bueis A; Rivas Jara L
    Eur J Ophthalmol; 2019 Jan; 29(1):9-14. PubMed ID: 29580102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil vs avastin as adjunct to conjunctival autograft in the surgical treatment of pterygium.
    Bekibele CO; Sarimiye TF; Ogundipe A; Olaniyan S
    Eye (Lond); 2016 Apr; 30(4):515-21. PubMed ID: 26987589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for pterygium recurrence after surgical excision with combined conjunctival autograft (CAG) and intraoperative antimetabolite use.
    Olusanya BA; Ogun OA; Bekibele CO; Ashaye AO; Baiyeroju AM; Fasina O; Ogundipe AO; Ibrahim AO
    Afr J Med Med Sci; 2014 Mar; 43(1):35-40. PubMed ID: 25335376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halting pterygium recurrence by postoperative 5-fluorouracil.
    Pikkel J; Porges Y; Ophir A
    Cornea; 2001 Mar; 20(2):168-71. PubMed ID: 11248822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limbal stem cell transplantation: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2008; 8(7):1-58. PubMed ID: 23074512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil versus mitomycin C as adjuncts to conjunctival autograft in preventing pterygium recurrence.
    Bekibele CO; Ashaye A; Olusanya B; Baiyeroju A; Fasina O; Ibrahim AO; Ogun O
    Int Ophthalmol; 2012 Feb; 32(1):3-8. PubMed ID: 22246200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and efficacy of intraoperative 5-fluorouracil infiltration in pterygium treatment].
    Valezi VG; Schellini SA; Viveiros MM; Padovani CR
    Arq Bras Oftalmol; 2009; 72(2):169-73. PubMed ID: 19466323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent Pterygium: A Review.
    Ghiasian L; Samavat B; Hadi Y; Arbab M; Abolfathzadeh N
    J Curr Ophthalmol; 2021; 33(4):367-378. PubMed ID: 35128181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil as chemoadjuvant for primary pterygium surgery: preliminary report.
    Akarsu C; Taner P; Ergin A
    Cornea; 2003 Aug; 22(6):522-6. PubMed ID: 12883344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison among adjuvant treatments for primary pterygium: a network meta-analysis.
    Fonseca EC; Rocha EM; Arruda GV
    Br J Ophthalmol; 2018 Jun; 102(6):748-756. PubMed ID: 29146761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study.
    Lekhanont K; Patarakittam T; Thongphiew P; Suwan-apichon O; Hanutsaha P
    Cornea; 2012 Feb; 31(2):155-61. PubMed ID: 22081150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of primary versus recurrent pterygium after intralesional 5-Fluorouracil.
    Malik S; Khan MS; Basit I
    J Pak Med Assoc; 2016 May; 66(5):559-62. PubMed ID: 27183936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subconjunctival mitomycin C as adjunctive therapy before pterygium excision.
    Donnenfeld ED; Perry HD; Fromer S; Doshi S; Solomon R; Biser S
    Ophthalmology; 2003 May; 110(5):1012-6. PubMed ID: 12750105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of pterygium surgery: analysis over 14 years.
    Fernandes M; Sangwan VS; Bansal AK; Gangopadhyay N; Sridhar MS; Garg P; Aasuri MK; Nutheti R; Rao GN
    Eye (Lond); 2005 Nov; 19(11):1182-90. PubMed ID: 15543190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.